US_chip

Washington eyes stake in Intel – and a bigger hand in America’s chip future

Key points:

  • Washington is considering an equity stake in Intel, signalling a shift from subsidising to owning strategic tech assets.
  • The move could inject capital and political backing into Intel’s delayed Ohio fab project, but also bring constraints.
  • For investors, the structure and terms of any deal will be as important as the headline.

The White House is weighing a move that could redefine America’s approach to industrial policy – taking an equity stake in Intel. If realised, it would be the boldest step yet from subsidising domestic chip production to actually owning part of a company deemed critical to national security.

Markets reacted instantly. Intel’s shares surged more than 7% in Thursday’s regular session and climbed another 4% after hours. That kind of jump reflects more than just optimism over short-term cash flow – it’s a sign investors understand the far-reaching implications of Washington becoming a shareholder in a USD 100 billion technology giant.

It would be a rare move in peacetime. The last comparable interventions were during the 2008–09 financial crisis, when the US government took stakes in General Motors and AIG. Then, the motive was survival. Now, it’s about resilience – building and safeguarding America’s capacity to produce the advanced semiconductors that power everything from smartphones to missile systems.

“This isn’t just about one company’s turnaround – it’s about the US putting skin in the game in a strategic tech war.”

How the Intel–Washington talks unfolded

  • Early August: President Trump publicly called for Intel CEO Lip-Bu Tan to resign over past business links to China.
  • Monday: Tan met with Trump at the White House, in what both sides described as a “constructive” meeting.
  • Thursday: Bloomberg reported the administration is considering buying a stake in Intel, potentially to accelerate the long-delayed Ohio manufacturing hub – once billed as the world’s largest chipmaking facility.

The discussions are still exploratory. No agreement has been reached on the size, price or structure of the stake, and both the White House and Intel emphasise the talks remain speculative.

Why this deal would mark a turning point for US industrial policy

This would mark a decisive evolution in the US government’s role in the semiconductor industry. Intel is already set to receive USD 8.5 billion in grants and access to USD 11 billion in loans under the CHIPS and Science Act. Moving from financial support to equity ownership would put Washington inside the room when strategic decisions are made.

The national security logic is clear. Taiwan produces most of the world’s leading-edge chips, making the US dependent on an island at the centre of geopolitical tensions. Intel is America’s only integrated chipmaker capable of manufacturing such chips domestically – but it is behind schedule and financially stretched.

For policymakers, an equity stake could help secure domestic capacity and ensure the Ohio fab gets built on a faster timeline. For investors, the calculus is more complex. A government buy-in might strengthen Intel’s balance sheet and bring stability to its turnaround. But it could also mean strategic decisions shaped by political priorities, not purely by shareholder value.

“When politics and production schedules collide, the outcome is never certain – but the stakes for Intel’s future just went up.”

Three possible deal structures – and why they matter for investors

  • Convertible preferred shares or warrants: Capital without immediate dilution, though potential overhang if converted.
  • Straight equity: Simple but likely tied to conditions on buybacks, dividends and manufacturing priorities.
  • ‘Golden share’: Minimal equity but maximum influence, with veto power over strategic moves.

The form matters. A clean, investor-friendly structure with limited strings could be a confidence boost. A deal loaded with political oversight could weigh on Intel’s agility – and its share price.

How a government stake could reshape Intel – and the chip industry

For Intel, the backing could provide the financial and political capital to keep its manufacturing ambitions alive. It could also give potential foundry customers more confidence in the company’s ability to deliver – particularly those prioritising secure, US-based production. But government involvement will almost certainly bring constraints on capital allocation, export compliance and where chips are made.

Competitors would also feel the ripple. Nvidia, AMD and Qualcomm could face subtle pressure to use Intel’s US fabs, supporting its foundry unit but potentially distorting competition. Abroad, rivals like TSMC and Samsung may push for increased state backing from their own governments, intensifying the global subsidy race in chips.

From a policy perspective, an equity stake would formalise a pattern of direct government involvement in strategic industries – from the “golden share” in US Steel to revenue-sharing agreements on semiconductor sales to China. This could easily expand beyond semiconductors if other sectors are judged too vital to leave solely to market forces.

Wall Street’s split view: lifeline or political overreach?

The immediate rally reflects hopes that a government partnership could rescue the Ohio project and cement Intel’s place in US chip strategy. But it also builds in expectations for a deal that may never happen, or that could emerge in a form less favourable than markets currently assume.

Some investors view this as a potential inflection point in Intel’s comeback. Others see nationalisation risk – a scenario where political goals outweigh commercial priorities. Either way, capital alone will not restore Intel’s technology leadership; it will still need to close the gap with TSMC in manufacturing and with Nvidia in AI.

The signals that could move Intel’s share price next

All eyes will be on official signals from the White House, Commerce Department and Pentagon. Any detail on stake size, governance rights or customer commitments for the Ohio fab will move the stock. Progress – or further delays – in Ohio construction will be another key indicator, as will news of major foundry client wins.

“Investors often talk about tailwinds. Here, the wind is coming straight from the West Wing – and it can just as easily change direction.”

Bottom line for investors – where opportunity meets political risk

For now, this is a political story with market consequences. Traders should be ready for volatility as headlines break. Longer-term investors need to focus less on whether Washington writes the cheque, and more on whether Intel can turn additional capital into technology parity and reliable foundry business.

The broader point is this: if Washington is willing to take a stake in Intel, it may be prepared to do the same in other “strategic” companies. That’s a shift worth considering across the portfolio – not just in semiconductors, but in any sector that could be deemed critical to national security in the years ahead.

 

 





This material is marketing content and should not be regarded as investment advice. Trading financial instruments carries risks and historic performance is not a guarantee of future results.

The instrument(s) referenced in this content may be issued by a partner, from whom Saxo receives promotional fees, payment or retrocessions. While Saxo may receive compensation from these partnerships, all content is created with the aim of providing clients with valuable information and options.

 

 

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.